In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
 
Status Schedule affected by COVID-19
Developed As CG

Project Team

Developer National Guideline Alliance

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
15 May 2020 Schedule affected by COVID-19. In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
13 May 2020 Stakeholder list updated
27 January 2020 Committee meeting
27 January 2020 Declaration of interests
15 November 2019 Scope published
19 March 2018 Committee list updated

For further information on the guideline development process, please read how we develop NICE guidelines